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Abstract 
Summary: Over the past decade, there has been an exponential increase in the amount of disease-
related genomic data available in public databases. However, this high-quality information is spread 
across independent sources and researchers often need to access these separately. Hence, there is a 
growing need for tools that gather and compile this information in an easy and automated manner. Here 
we present “VarGen”, an easy to use, customisable R package that fetches, annotates and rank variants 
related to diseases and genetic disorders, using a collection public databases (viz. OMIM, FANTOM5, 
GTEx and the GWAS catalog). This package is also capable of annotating these variants to identify the 
most impactful ones. We expect that this tool will benefit the research of variant-disease relationships. 
Availability and implementation: VarGen is open-source and freely available via GitHub: 
https://github.com/MCorentin/VarGen. The software is implemented as an R package and is supported 
on Linux, MacOS and Windows. 
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction 
Complex genetic diseases are often caused by the accumulation of 
a large number of low impacting variants rather than a single de-
fective gene. With the current epidemics of complex non-transmit-
table diseases such as diabetes mellitus and obesity and the recent 
advances in sequencing technologies and genotyping, it is nowa-
days possible to gain comprehensive insights into the genetics be-
hind these disorders. Moreover, there has been an exponential in-
crease in the amount of high-quality information available in public 
databases, for example, the current build of dbSNP contains more 
than 660 million human RefSNP clusters (Sherry et al. 2001). Un-
fortunately, useful information is often scattered between independ-
ent sources, such as the Online Mendelian Inheritance in Man 
(OMIM), the Functional Annotation Of the Mammalian genome 5 
(FANTOM5), the Genotype-Tissue Expression (GTEx) and Ge-
nome Wide Association Studies (GWAS). Each one of these data-
bases provide useful and complementary information about the im-
pact of variants on diseases but have to be accessed separately 
and sometimes are not based on the same version of the human 
genome. Some previous attempt to integrate SNP-related 
knowledge already exist [e.g. (Cao et al. 2017; Ferrero 2018; Pinero 
et al. 2017)], but these often lack completeness and/or the sensitiv-
ity required. Here we present VarGen, an easy-to-use R package 
for disease-associated variant discovery and annotation based on 
information integrated from different and complementary high-qual-
ity databases. 
2 VarGen 
VarGen implements a highly customisable workflow for retrieving 
and annotating SNPs using publicly available repositories (See 
Supplementary Figure 1). The workflow’s entry point is typically a 
disease ID entered by the user. Alternatively, VarGen can retrieve 
causative SNPs based on a customised list of genes of interest. 
Genes related to the disease are first retrieved from the OMIM da-
tabase (Amberger and Hamosh 2017), subsequently called the 
“OMIM genes”.  VarGen then retrieves variants situated directly on 
the OMIM genes, as well as variants present in their promoter re-
gions using the FANTOM5 database. Integrating FANTOM5 data 
will allow the detection of non-coding variants, as there is more and 
more evidence of their non-negligible impact  on diseases (Ward 
and Kellis 2012). Additionally, tissue-specific SNPs can also be re-
trieved using the Genotype-Tissue Expression eQTLs database 
C. Molitor et al. 
(Consortium et al. 2017). VarGen also accesses the GWAS cata-
logue to get variants associated with GWAS traits of interest 
(Buniello et al. 2019). VarGen, accesses these databases via Bi-
omaRt (Smedley et al. 2009), Ensembl API and local files. The lat-
ter can be downloaded via the vargen_install function, making 
the installation straightforward. Moreover, all the positions are re-
ported in hg38 coordinates. If a source still uses hg19, VarGen will 
lift-over the positions. The variants are then annotated according to 
their location, impact, clinical significance, and scored with the 
Combined Annotation Dependent Depletion (CADD) phred score 
(Rentzsch et al. 2019). Since VarGen typically outputs a large num-
ber of variants as a result of the comprehensive list of repositories 
queried, this annotation step is helpful to rank them and identify the 
most relevant. 
VarPhen, a more specific alternative pipeline is also available within 
the package. VarPhen limits the variant output by retrieving the var-
iants directly linked to a list of phenotypes in BiomaRt. The list of 
phenotypes is automatically obtained from keywords entered by the 
user as input (See Supplementary Figure 2). 
In order to have an overview of the variants discovered by the pipe-
line, we developed a custom visualisation function, which displays 
the variants on each OMIM gene, grouped by according to their 
corresponding impact (See Supplementary Figure 3). 
3 Benchmarking 
VarGen was compared to two other similar tools: DisGeNET and 
VarFromPDB using the term “obesity” (OMIM: 601665) as a use 
case. The benchmarking script is available as supplementary data.
Results of the benchmarking can be seen on Figure 1 
Figure 1: Venn diagram of the variants obtained with the different 
pipelines. Obesity (OMIM: 601665) was chosen as a use case. 
VarGen and VarPhen are the two alternative pipelines available in 
the package, focused on sensitivity and specifity respectively. 
VarGen and VarPhen are sharing respectively 456 and 365 vari-
ants with DisGeNET and VarFromPDB. Moreover, 882 variants are 
shared only between VarGen and VarPhen, highlighting the higher 
sensitivity of both pipelines. 
In total, DisGeNET and VarFromPDB are sharing 68 variants and 
only 2 of them are not discovered by either VarGen or VarPhen. 
Almost all of the 584 variants unique to DisGeNET are from litera-
ture mining and GwasDB which are not implemented in the other 
pipelines (see Supplementary Figure 4). Arguably, literature mining 
may introduce a large number of false positives and therefore was 
not included in our package. It was found that 408 variants out of 
the 479 variants unique to VarFromPDB are not associated directly 
with obesity but other phenotypes, such as Leptin dysfunction, In-
tellectual Disability, Bardet-Biedl syndrome; which therefore ex-
plains the limited overlap with the other tools (See Supplementary 
Figure 5 and Supplementary Table 1). 
Some of the 119,243 unique variants from VarGen are potentially 
false positives or with little confirmed clinical evidence. It is possible 
to filter most of them using the phred score, source and clinical sig-
nificance while keeping almost all the variants found by the other 
databases. (See Supplementary Figure 6). As some users will pre-
fer a more specific approach, we provide an alternative pipeline, 
VarPhen, which gets only the most relevant variants. 
Similarly, an additional benchmarking has been carried using Alz-
heimer’s disease (OMIM ID: 104300) as a use-case, where the re-
sults were comparable to these for obesity described above (See 
Supplementary Figures 7 to 9 and Supplementary Table 2).
4 Conclusions 
VarGen is a flexible, well documented and easy to use R package 
for disease-related SNP discovery. The pipeline offers higher de-
gree of sensitivity compared to other existing tools, notably be-
cause it uses databases often overlooked by other tools (e.g. 
FANTOM5). The output is a comprehensive list of annotated vari-
ants, ranked according to their phred score and clinical impact, 
which can also be visualised within a genome visualisation track.
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Supplementary Material S1: User Manual
VarGen
VarGen is an R package designed to get a list of variants related to a disease. It
just need an OMIM morbid ID as input and optionally a list of tissues / gwas
traits of interest to complete the results. You can use your own customised list of
genes instead of an OMIM ID. VarGen is also capable of annotating the variants
to help you rank and identify the most impactful ones.
All the coordinates are based on the hg38 version of the human genome.
VarGen is open-source and available on GitHub
Table of Contents
• VarGen




– Install VarGen with devtools
– Install VarGen from source
• Preparing the input
– Obtaining the local files
– Getting the OMIM id
– Getting the GTEx tissues
– Getting the gwas traits
• How to use VarGen
– Launching the pipeline
– Annotating the variants
– Filtering the variants
• Alternative pipelines
– VarPhen
– Customised list of genes
1
• Tips
– How to plot the gwas variants
– How to plot the omim variants
VarGen workflow
This pipeline is centred on the genes linked to the disease of interest in the
Online Mendelian Inheritance in Man (subsequently called the “OMIM genes”).
VarGen is designed as a discovery tool, if you want a more specific pipeline see
“VarPhen” in “Alternative pipelines”.
VarGen outputs variants from the following sources: - OMIM: Variants located
directly on the “OMIM genes”. - FANTOM5: Variants located on the enhancers
/ promoters of the “OMIM genes”. - GTEx: Variants associated with a change
in expression for the “OMIM genes”, in certain tissues. Currently GTEx v7 and
v8 are supported. - GWAS catalog: Variants associated with the phenotype
of interest.
The variants are then annotated with myvariant.




VarGen needs the following: - R (tested on version 3.6) - An internet connec-
tion - The following R libraries: (The number is the version tested during
development)
Bioconductor (3.9) biomaRt (2.40.3) gtools (3.8.1)
gwascat (2.16.0) jsonlite (1.6) GenomeInfoDb (1.20.0)
IRanges (2.18.1) httr (1.4.1) BiocGenerics (0.30.0)
stringr (1.4.0) utils (3.6.0) splitstackshape (1.4.8)
ggplot2 (3.2.1) rtracklayer (1.44.2) BiocManager (1.30.4)
R.utils (2.9.0) myvariant (1.14.0) GenomicRanges (1.36.0)
• Optional R libraries (needed for the visualisation functions: var-
gen_visualisation and plot_manhattan_gwas):
Gviz (1.28.1) ggbio (>= 1.32.0) grDevices (>= 3.6.0)
To install the dependencies you can use the following command in R (it might
take a while depending on your connection):






"utils", "splitstackshape", "ggplot2", "rtracklayer",
"R.utils", "myvariant"), dependencies = TRUE)
note: “R.methodsS3” and “R.oo” will be installed as dependencies of “R.utils”
Install VarGen with devtools




install_github(repo = "MCorentin/VarGen", dependencies = TRUE)
library(VarGen)
Install VarGen from source
Alternatively you can clone the GitHub repository:
git clone https://github.com/MCorentin/VarGen
Then open R and install the package script from source:
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library(utils)
install.packages("./VarGen/", repos = NULL, type = "source")
Preparing the input
Obtaining the local files
VarGen is fetching data from public databases, it needs the following files
(they should all be in the same folder). The easiest way to get them is to use
the vargen_install function from this package. The list of files obtained by
the function is available below (with their approximate sizes and the links to
download them manually). note: The installation can take a while, especially
for the GTEx files.
vargen_install(install_dir = "./vargen_data",
gtex_version = "v8", verbose = T)
Alternatively, they can be installed manually (the approximate size of every file
is written in parenthesis next to the filename):
• enhancer_tss_associations.bed (~10 Mb), this is the enhancer to
transcript start site association file from FANTOM5. (available at:
http://enhancer.binf.ku.dk/presets/enhancer_tss_associations.bed)
• hg19ToHg38.over.chain (~500 kb), some databases are still us-
ing information from the human reference genome “hg19”. VarGen
will use this file to liftover the information to “hg38” (available at:
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/liftOver/hg19ToHg38.over.chain.gz)
• GTEx_Analysis_v8_eQTL (~1.45 Gb), a folder containing the signif-
icant variant gene pairs from the Genotype-Tissues Expression database
(GTEx) (available at: https://gtexportal.org/home/datasets). v7 and v8
are supported by VarGen.








• gwas catalog file (~90 Mb), this is an optional file. Depending on your
connection, creating the lastest gwas catalog using makeCurrentGwascat
function can take a long time. You can instead download a gwas catalog
file from http://www.ebi.ac.uk/gwas/api/search/downloads/alternative
and give it as input for the VarGen pipeline.
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note: VarGen will use the name of the file to get the extract date, so it needs
to be in the format: [filename]_rYYYYY-MM-DD.tsv
Getting the OMIM id
The OMIM morbid ID is the starting point of the pipeline, from it VarGen
will get the genes associated to the disease. You can obtain it from the OMIM
website https://omim.org/ or using the list_omim_accessions function. In our
case we will use “obesity leanness included” (OMIM id: 601665).
gene_mart <- connect_to_gene_ensembl()
View(list_omim_accessions(gene_mart))
# You can search using list of keywords as well:
View(list_omim_accessions(gene_mart, c("alzheimer", "neurodegeneration")))
Getting the GTEx tissues
This database will be used to get tissue-specific variants that are affecting the
expression of the genes related to the disease. You can obtain the list of files
with the list_gtex_tissues function.
list_gtex_tissues(gtex_dir = "./vargen_data/GTEx_Analysis_v8_eQTL/")
#> keywords filepaths
#> 1 Adipose_Subcutaneous vargen_data/GTEx_Analysis_v8_eQTL/\
Adipose_Subcu.v8.signif_variant_gene_pairs.txt.gz
#> 2 Adipose_Visceral_Omentum vargen_data/GTEx_Analysis_v8_eQTL/\
Adipose_Vis_Omentum.v8.signif_variant_gene_pairs.txt.gz
#> 3 Adrenal_Gland vargen_data/GTEx_Analysis_v8_eQTL/\
Adrenal_Gla.v8.signif_variant_gene_pairs.txt.gz
#> 4 Artery_Aorta vargen_data/GTEx_Analysis_v8_eQTL/\
Artery_Aor.v8.signif_variant_gene_pairs.txt.gz
#> ...
To select the GTEx tissues of interest you can use the select_gtex_tissues









Getting the gwas traits
The gwas traits will be used to get associated variants in the gwas catalog
(https://www.ebi.ac.uk/gwas/). You can search the available gwas traits by
keyword with the list_gwas_traits function. Here we are going to use a local
gwas catalog file (gwas_catalog_v1.0.2-associations_e96_r2019-08-24.tsv).
obesity_traits <- list_gwas_traits("obesity", "./vargen_data")
obesity_traits
#> [1] "Obesity (extreme)"
#> [2] "Obesity-related traits"
#> [3] "Obesity"
#> [4] "Obesity (early onset extreme)"
#> [5] "Obesity in adult survivors of childhood
cancer exposed to cranial radiation"
#> [6] "Obesity in adult survivors of childhood
cancer not exposed to cranial radiation"
#> [7] "Bilirubin levels in extreme obesity"
#> [8] "Type 2 diabetes (young onset) and obesity"
#> [9] "Obesity and osteoporosis"
#> [10] "Hepatic lipid content in extreme obesity"
#> [11] "Hyperinsulinemia in obesity"
How to use VarGen
Launching the pipeline
VarGen main entry point is the vargen_pipeline function.
The mandatory inputs are: - The folder with the installed files, “./vargen_data/”
in our case (see “Obtaining the local files”) - A OMIM morbid id, “601665” in
our case (see “Getting the OMIM id”). - An output directory, where information
about the variants and the genes will be written. The default is the current
directory “./”.
The optional inputs are: - A fantom5 correlation threshold, the higher it is, the
stricter you are about association between genes and enhancers. The default is
0.25 - A list of GTEx tissues (see “Getting the GTEx tissues”) - A list of gwas
traits (see “Getting the gwas traits”)
Now we can launch the pipeline with all the input data:
adipose_tissues <- select_gtex_tissues("./vargen_data/GTEx_Analysis_v8_eQTL/",
"adipose")
obesity_traits <- list_gwas_traits("obesity", "./vargen_data/")






You will obtain a data.frame with the list of variants, their position on GRCh38,
the ensembl id and hgnc gene symbol of the gene associated with the variant
and the source (omim, fantom5, gtex or gwas).
head(obesity_variants)
# chr pos rsid ensembl_gene_id hgnc_symbol source
#> chr2 25160855 rs777983882 ENSG00000115138 POMC omim
#> chr2 25160866 rs1480805741 ENSG00000115138 POMC omim
#> chr2 25160871 rs1245939527 ENSG00000115138 POMC omim
#> chr2 25160872 rs1219237056 ENSG00000115138 POMC omim
#> chr2 25160877 rs1453226041 ENSG00000115138 POMC omim
#> chr2 25160879 rs566456581 ENSG00000115138 POMC omim
Annotating the variants
This pipeline is designed as a discovery analysis, to identify potential new
variants, you should not expect every variants from the pipeline to
have an effect on the phenotype. Annotating the variants will help you
defining which variants to keep or discard. To annotate the variants you can use
the annotate_variants function with the list of rsids obtained with the vargen
pipeline. This uses myvariant.info to annotate the variants and may take some
time depending on your internet connection.
The annotation contains: - CADD Phred score: ranging from 1 to 99, based
on the rank of each variant relative to all possible 8.6 billion substitutions
in the human reference genome. A higher value means a more deleterious
variant. (above 10 means the variant is in the top 10%, above 20 in the
top 1%). - fathmm-xf score: between 0 and 1, a higher value means a more
deleterious variant. (more confidence closer to 0 or 1) - fathmm-xf prediction:
“D” (DAMAGING) if score > 0.5 or “N” (NEUTRAL) otherwise. - Annotation
type: information about the variant location (eg: coding, non-coding, regulatory
region. . . ) - Consequence: gives more information on the functionnal effect
(eg: REGULATORY, DOWNSTREAM, STOP_GAINED, SPLICE-SITE. . . )
- ClinVar clinical significance: standard to report the clinical significance of
certain variants (eg: “benign”, “pathogenic”, “drug response” etc. . . .). - snpEff
impact: assessment of the putative impact of the variant (HIGH, MODERATE,
MODIFIER or LOW).
/! Due to the different transcripts for a same gene, some variants will appear
more than once with a different annotation, this is expected. You can check the
variant position on the different isoforms with the vargen_visualisation function.
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obesity_annotation <- annotate_variants(obesity_variants$rsid, verbose = T)
# Merging the output of the annotation with VarGen output, using the "rsid" column
obesity_ann <- merge(obesity_variants, obesity_annotation)
# We advise you to write the variants in a file,
#so you will not have to run the pipeline again.
write.table(x = obesity_ann, quote = FALSE, row.names = FALSE,
file = "./OMIM_601665/vargen_variants_annotated.tsv", sep = "\t")
Output after annotation:
Filtering the variants
As VarGen is outputting a lot of variants, you may want to filter the results.
The filtering strategy is dependent on your preferences. VarGen outputs an R
data.frame containing information about each variant. You can focus on clinically
significant variants (“pathogenic”, “likely pathogenic” etc. . . ), on variants with
a high phred score etc. . .
You can even combine different filtering, for example we found that keeping all the
variants from the gwas catalog and with clinical significance while removing the
variants with a cadd phred score lower than 10 was removing a lot of potentially
false positive results:
vargen_phred_10 <- obesity_ann [obesity_ann$cadd_phred > 10,]
vargen_phred_10 <- vargen_phred_10[!is.na(vargen_phred_10$cadd_phred),]
vargen_clinVar <- obesity_ann [obesity_ann$clinical_significance != "",]
vargen_gwas <- obesity_ann[obesity_ann$source == "gwas",]
#Concatenating the different filtering




A more specific, alternative pipeline is available as part of this package, called
“VarPhen”, it outputs a smaller list of variants, but directly related to the disease
of interest. It relies on biomaRt to link variants to phenotypes.
note: You will need to specify the columns to merge the results from VarPhen
(“redsnp_id”) and the annotation (“rsid”). cf: the example below.
Figure 2: VarPhen workflow
Example with obesity:
# First connect to snp ensembl
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snp_mart <- connect_to_snp_ensembl()
obesity_phens <- get_phenotype_terms(keyword = "obesity",
snp_mart = snp_mart)
obesity_varphen <- get_variants_from_phenotypes(phenotypes = obesity_phens,
snp_mart = snp_mart)
obesity_varphen_annotation <- annotate_variants(obesity_varphen$refsnp_id)
# /!\ contrary to vargen, here you need to specify which columns to merge
# "refsnp_id" for varphen, and "rsid" for the annotation.
obesity_varphen_annotated <- merge(obesity_varphen,
obesity_varphen_annotation,
by.x = "refsnp_id", by.y = "rsid")
Output example:
Figure 3: VarPhen output
Customised list of genes
If instead of an OMIM id you are interested in a specific list of genes, you can use
the vargen_custom function with a list of ensembl gene ids. This take the same
input as vargen_pipeline (except the omim id) and follow the same workflow




obesity_traits <- list_gwas_traits("obesity", "./vargen_data/")
obesity_custom <- vargen_custom(vargen_dir = "./vargen_data/",







How to plot the gwas variants
If you want to visualise the variants in a manhattan plot, you can use the
plot_manhattan_gwas function:
gwas_cat <- create_gwas("./vargen_data/")
alzheimer_traits <- c("Alzheimer s disease",
"Alzheimer s disease (late onset)",
"Alzheimer s disease biomarkers",
"Alzheimer s disease (cognitive decline)")
plot_manhattan_gwas(gwas_cat = gwas_cat, traits = alzheimer_traits)
# Optional: if you want to save the plot as a pdf
grDevices::dev.print(pdf, "./manhanttan_alzheimer.pdf")
Figure 4: Example of manhanttan plot for alzheimer’s disease
The two thresholds, suggestive and significant, correspond to the definition given
by Lander and Kruglyak:
Lander E, Kruglyak L. Genetic dissection of complex traits:
guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11(3):241-7.
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How to plot the omim variants
You can use the vargen_visualisation function to have an overview of the variants
located on the omim genes. Note that one variant can be represented multiple
times, as it consequence and phred score will be different according to each
transcript.
# cf:  Annotating the variants  to create "vargen_variants_annotated.tsv":
obesity_vargen_ann <- read.table(file = "./OMIM_601665/vargen_variants_annotated.tsv",






The plot contains 4 tracks: - The chromosome, with a red marker on the gene
location - The ensembl transcripts - The variant consequences, grouped by type
(eg: INTRONIC, STOP LOST etc. . . ), each green bar represent a variant - The
cadd phred score, each dot represent a variant.
Figure 5: vargen visualisation





vargen_visualisation(annotated_snps = obesity_vargen_ann, verbose = T,





[obesity_vargen_ann$cadd_phred > 20, "rsid"]))
Figure 6: vargen visualisation with highlighted variants
More examples
In the following example we are assuming that the files described in “Installation”
have been installed in the folder “./vargen_data”, either manually or by running:
vargen_install("./vargen_data")
• Example 1: “Simple query for Type 1 Diabetes Mellitus”
T1DM_variants <- vargen_pipeline(vargen_dir = "./vargen_data",
omim_morbid = "222100")
• Example 2: “Type 1 Diabetes Mellitus with GTEx”
# First select the tissues of interest (here pancreas)
# it is possible to select more than one tissue (eg: c("pancreas", "adipose"))
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pancreas_gtex <- select_gtex_tissues(gtex_dir = "./vargen_data/GTEx_Analysis_v8_eQTL/",
tissues_query = "pancreas")
T1DM_variants <- vargen_pipeline(vargen_dir = "./vargen_data",
omim_morbid = "222100",
gtex_tissues = pancreas_gtex)
• Example 3: “Obesity with GTEx, GWAS and annotation”
# First select the tissues of interest (here adipose)
# it is possible to select more than one tissue (eg: c("pancreas", "adipose"))
adipose_gtex <- select_gtex_tissues(gtex_dir = "./vargen_data/GTEx_Analysis_v8_eQTL/",
tissues_query = "adipose")
# List the available gwas traits:
list_gwas_traits(keywords = "obesity")
# Select gwas traits of interest
gwas_obesity <- c("Obesity (extreme)",
"Obesity-related traits",
"Obesity", "Obesity (early onset extreme)")






# Annotation of the variants obtained with the previous command:
Obesity_annotation <- annotate_variants(rsid = Obesity_variants$rsid)
# Merging the original output with the annotation:
Obesity_variants_annotated <- merge(Obesity_variants, Obesity_annotation)
View(Obesity_variants_annotated)
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Supplementary Figure 1: VarGen workflow: user inputs and public databases are represented by 
green and blue boxes respectively. The pipeline is centred on the list of genes related to the disease 
in the Online Mendelian Inheritance in Man (subsequently called the “OMIM genes”). VarGen gets the 
variants located directly on the OMIM genes, as well as on their enhancers and promoters, using 
FANTOM5. GTEx is used to get tissue-specific variants impacting the expression of the OMIM genes. 
Finally, the user can also input a list of gwas traits to get variants from gwas catalogue. The package 
also offers the possibility to annotate the variants. The databases are accessed using BiomaRt, 
Ensembl API and local files. The only mandatory input is an OMIM ID or alternatively, a customised 





Supplementary Figure 2: VarPhen workflow: user inputs and public databases are represented by 
green and blue boxes respectively. VarPhen is a more specific, alternative pipeline, available within 
the package. The pipeline starts by fetching biomaRt to get all the phenotypes related to a user 
entered keyword. The user can then use one or more of these phenotypes to get the list of associated 
variants in biomaRt. As with VarGen it is possible to annotate them to obtain further information the 




















Supplementary Figure 3: Visualisation created with VarGen for the PPARGC1B gene. In order to have an overview of the variants, the vargen_visualisation 
function was written. This plot is created for each gene and contains four tracks, from top to bottom: 1) the chromosome with a red marker on the gene locus 
2) the ensembl transcripts with the exons represented as purple blocks 3) the variants represented by green bars and grouped by consequences 4) The 
variants represented by blue dots and plotted according to their cadd phred score, with higher scores meaning a more deleterious variant. It is also possible 
to highlight some variants by rsid (not showed in the figure).
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Supplementary Figure 4: Venn diagrams representing the variants found by the different pipelines 
during benchmarking: VarGen, DisGeNET, V and VarPhen. Obesity (OMIM: 601665) was chosen as 
the use case. A. Results with the raw output for all the pipelines. B. Results using only the literature 
mining (BEFREE) for DisGeNET. C. Results using only the gwasDB database for DisGeNET D. 
Results using the others DisGeNET databases (gwasdb, uniprot and clinvar). Most of the variants 













Supplementary Figure 5: Venn diagrams representing the variants found by the different pipelines 
during benchmarking: VarGen, DisGeNET, VarFromPDB and VarPhen. Obesity (OMIM: 601665) was 
chosen as the use case. A. Results with the raw output for all the pipelines. B. Results obtained when 
filtering the variants by phenotypes containing the word “obesity” for VarFromPDB. Most of 






Supplementary Figure 6: Venn diagrams representing the variants found by the different pipelines 
during benchmarking:,VarGen, DisGeNET, VarFromPDB and VarPhen. Obesity (OMIM: 601665) was 
chosen as the use case. A. Venn diagram using the raw output for all the pipelines. B. Venn diagram 
using the filtered VarGen dataset, with the following strategy: all the variants from the gwas catalogue 
and with clinical significance were kept, and the rest were filtered if their cadd phred score was below 
10. 
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Supplementary Figure 7: Venn diagrams representing the variants found by the different pipelines 
during benchmarking: VarGen, DisGeNET, V and VarPhen. Alzheimer (OMIM: 104300) was chosen 
as the use case. A. Results with the raw output for all the pipelines. B. Results using only the 
literature mining (BEFREE) for DisGeNET. C. Results using only the gwasDB database for DisGeNET 
D. Results using the others DisGeNET databases (gwasdb, uniprot and clinvar). Most of the variants 








Supplementary Figure 8: Venn diagrams representing the variants found by the different pipelines 
during benchmarking: VarGen, DisGeNET, VarFromPDB and VarPhen. Alzheimer (OMIM: 104300) 
was chosen as the use case. A. Results with the raw output for all the pipelines. B. Results obtained 
when filtering the variants by phenotypes containing the word “alzheimer” for VarFromPDB. Most of 






Supplementary Figure 9: Venn diagrams representing the variants found by the different pipelines 
during benchmarking:,VarGen, DisGeNET, VarFromPDB and VarPhen. Alzheimer (OMIM: 104300) 
was chosen as the use case. A. Venn diagram using the raw output for all the pipelines. B. Venn 
diagram using the filtered VarGen dataset, with the following strategy: all the variants from the gwas 
catalogue and with clinical significance were kept, and the rest were filtered if their cadd phred score 




Supplementary Table 1: List of phenotypes found with VarFromPDB using the keyword "Obesity" as 
input 
not provided Progressive sclerosing poliodystrophy 
not specified OBESITY (BMIQ14), SUSCEPTIBILITY TO 
Arterial calcification of infancy Autistic behavior 
Hypophosphatemic Rickets, Recessive Myopia 
Abetalipoproteinaemia Seizures 
Inborn genetic diseases Strabismus 
Abnormality of neuronal migration Coffin-Siris syndrome 
Monogenic Non-Syndromic Obesity Rhabdoid tumor predisposition syndrome 2 
Proopiomelanocortin deficiency intellectual deficiency 
History of neurodevelopmental disorder Hearing impairment 
Intellectual Disability, Recessive Hypothyroidism 
Mental retardation, autosomal recessive 13 Intellectual disability 
Joubert syndrome Short metacarpal 
Obesity, autosomal dominant Short stature 
Monogenic diabetes Truncal obesity 
Obesity Attention deficit hyperactivity disorder 
salbutamol response - Efficacy Delayed speech and language development 
salmeterol response - Efficacy Infantile muscular hypotonia 
antipsychotics response - Toxicity/ADR Malar flattening 
amisulpride response - Toxicity/ADR Mandibular prognathia 
aripiprazole response - Toxicity/ADR Misalignment of teeth 
clozapine response - Toxicity/ADR Poor fine motor coordination 
haloperidol response - Toxicity/ADR Thin upper lip vermilion 
olanzapine response - Toxicity/ADR Brachydactyly 
paliperidone response - Toxicity/ADR Cognitive impairment 
quetiapine response - Toxicity/ADR Cushing's syndrome 
risperidone response - Toxicity/ADR Hypocalcemia 
ziprasidone response - Toxicity/ADR McCune-Albright syndrome 
DEVELOPMENTAL DELAY, 
INTELLECTUAL DISABILITY, 
OBESITY, AND DYSMORPHISM 
Short stature, brachydactyly, 
intellectual developmental disability, and 
seizures  
EPILEPTIC ENCEPHALOPATHY, 
EARLY INFANTILE, 58 
Progressive osseous heteroplasia 
Leptin receptor deficiency Pseudohypoparathyroidism 
Diabetes Mellitus, Noninsulin-Dependent, 
with Acanthosis Nigricans and Hypertension 
Pseudohypoparathyroidism type 1B 
Familial partial lipodystrophy Pseudohypoparathyroidism type 1C 
Proprotein convertase 1/3 deficiency Pseudopseudohypoparathyroidism 
Leptin deficiency or dysfunction Round face 
Spastic paraplegia, intellectual disability, 
nystagmus, and obesity 
Subcutaneous nodule 
Joubert Syndrome and Related Disorders Tetany 
Obesity, hyperphagia, and developmental delay Abnormal facial shape 
Bardet-Biedl syndrome Abnormality of the dentition 
Syndromic intellectual disability Acanthosis nigricans 
Familial partial lipodystrophy 3 Hepatic steatosis 
BODY MASS INDEX QUANTITATIVE TRAIT 
LOCUS 20 
Hyperlipidemia 
Neuroblastoma Insulin resistance 
Diabetes mellitus type 2 Intellectual disability, severe 
Hypophosphatemic rickets, autosomal 
recessive, 2 
Lumbar hyperlordosis 
PHIP-Related disorders Renal hypoplasia 
Schizophrenia Self-injurious behavior 
- PITUITARY ADENOMA 3, MULTIPLE TYPES 
LEPR-Related Disorders Abnormal platelet function 
POMC-Related Disorders Abnormal platelet morphology 
ENPP1-Related Disorders Abnormal platelet shape 
Joubert syndrome 1 Epistaxis 
MORM syndrome Hypertension 
Absent epiphyses Increased mean platelet volume 
Chronic lung disease Numerous pigmented freckles 
Cleft palate Thrombocytopenia 
Coat hanger sign of ribs Difficulty walking 
Hemivertebrae Generalized hypotonia 
Interstitial pulmonary abnormality Gynecomastia 
Micrognathia Horizontal nystagmus 
Patent ductus arteriosus Muscular hypotonia 
Preaxial foot polydactyly Pes planus 
Pseudoarthrosis Poor motor coordination 
Respiratory failure Sleep disturbance 
Short femur Neurological speech impairment 
Skeletal dysplasia Pigmentary retinopathy 
Talipes equinovarus Immunodeficiency 
Vertebral hypoplasia Protruding tongue 
Vertebral segmentation defect Severe T-cell immunodeficiency 
Metabolic syndrome, susceptibility to Cardiomyopathy 
Obesity, age at onset of Gastroesophageal reflux 
Obesity, mild, early-onset Glaucoma 
Leanness, inherited Limb-girdle muscle weakness 
Obesity, late-onset Muscle weakness 
Obesity, severe, and type II diabetes Obstructive sleep apnea syndrome 
UCP3 POLYMORPHISM G/A Panhypopituitarism 
Morbid obesity Specific learning disability 
Body mass index, modifier of Microcephaly 
Diabetes mellitus, noninsulin-dependent, 
modifier of 
Obesity, variation in 
Intimal medial thickness of internal carotid 
artery, modifier of 
Bardet-Biedl syndrome 8 
Obesity, modifier of Intellectual disability, moderate 
Carcinoma of colon Postaxial foot polydactyly 
Glioma susceptibility 1 Non-ketotic hyperglycinemia 
LEPTIN RECEPTOR POLYMORPHISM Cardiovascular phenotype 
Obesity, association with Congenital long QT syndrome 
Obesity, early-onset, susceptibility to Long QT syndrome 
Insulin resistance, susceptibility to Long QT syndrome 2 
Body mass index quantitative trait locus 12 Prolonged QT interval 
Metabolic syndrome, protection against Asthma 
Asthma, nocturnal, susceptibility to Breast-ovarian cancer, familial 2 
ADRB2 POLYMORPHISM Ectopic ossification 
Beta-2-adrenoreceptor agonist, reduced 
response to 
Headache 
Body mass index quantitative trait locus 18 Hereditary breast and ovarian cancer syndrome 
Cole disease Hereditary cancer-predisposing syndrome 
Morbid obesity and spermatogenic failure Migraine 
Abdominal obesity-metabolic syndrome 3 Nephrolithiasis 
See cases Short attention span 
Leptin dysfunction Striae distensae 
Retinal dystrophy and obesity Spastic paraplegia 54, autosomal recessive 
PHIP-Related Disorder Dolichocephaly 
Generalized epilepsy Macrocephalus 
Global developmental delay NA 
Mild obesity  
 
  
Supplementary Table 2: List of phenotypes found with VarFromPDB using the keyword "Alzheimer" 
as input 
Alzheimer disease, susceptibility to Genetic prion diseases 
Cutaneous photosensitivity Gerstmann-Straussler-Scheinker syndrome 
Hemochromatosis type 1 Huntington disease-like 1 
Hemochromatosis type 2 Jakob-Creutzfeldt disease 
Hemochromatosis, juvenile, digenic Inborn genetic diseases 
Hereditary cancer-predisposing syndrome Alzheimer disease, early-onset, susceptibility to 
Hereditary hemochromatosis Aphasia, primary progressive, susceptibility to 
Microvascular complications of diabetes 7 Fatal familial insomnia 
Porphyria cutanea tarda, susceptibility to Prion disease, susceptibility to 
Porphyria variegata, susceptibility to not specified 
Porphyrinuria 
Spongiform encephalopathy with europsychiatric  
features 
Transferrin serum level quantitative trait locus 2 Protection against Creutzfeldt-Jakob disease 
not provided Kuru, protection against 
Alzheimer's disease Coronary artery spasm 1, susceptibility to 
Familial porphyria cutanea tarda Hypertension resistant to conventional therapy 
Variegate porphyria 
Hypertension, pregnancy-induced, susceptibility 
to 
HFE INTRONIC POLYMORPHISM Ischemic heart disease, susceptibility to 
HFE POLYMORPHISM Ischemic stroke, susceptibility to 
Myeloperoxidase deficiency Metabolic syndrome, susceptibility to 
POLYCYSTIC LIPOMEMBRANOUS 
OSTEODYSPLASIA WITH SCLEROSING 
LEUKOENCEPHALOPATHY 2 
Apolipoproteinemia E1 
Polycystic lipomembranous osteodysplasia with 
sclerosing leukoencephalopathy 
Familial type 3 hyperlipoproteinemia 
Alzheimer disease, type 4 Warfarin response 
Dilated cardiomyopathy 1V atorvastatin response - Efficacy 
Alzheimer disease, late-onset, susceptibility to 
HYPERLIPOPROTEINEMIA, TYPE III, AND  
ATHEROSCLEROSIS ASSOCIATED WITH 
APOE5 
Alzheimer disease, familial, 3, with unusual 
plaques 
HYPERLIPOPROTEINEMIA, TYPE III, AND  
ATHEROSCLEROSIS ASSOCIATED WITH 
APOE7 
Dilated cardiomyopathy APOE2-DUNEDIN 




CEREBRAL AMYLOID ANGIOPATHY, PRNP-
RELATED 
APOE4(-)-FREIBURG 
Quebec platelet disorder Alzheimer disease 2 
Alzheimer disease, protection against 
Primary degenerative dementia of the Alzheimer 
type, presenile onset 
Major depressive disorder APOE3(-)-FREIBURG 
Reticulate acropigmentation of Kitamura APOE3 VARIANT 
Alzheimer disease 18 APOE2 VARIANT 
Dilated Cardiomyopathy, Dominant APOE4(+) 
Early-Onset Familial Alzheimer Disease Myocardial infarction 
Dementia Lipoprotein glomerulopathy 
Mental deterioration Cerebral amyloid angiopathy, APP-related 
Alzheimer disease familial 3, with spastic 
paraparesis 
Alzheimer disease, type 1 
Sea-blue histiocyte syndrome 
CEREBRAL AMYLOID ANGIOPATHY,  
APP-RELATED, PIEDMONT VARIANT 
See cases Alzheimer disease, type 3 
Primary dilated cardiomyopathy Acne inversa, familial, 3 
Hirschsprung disease 1 Frontotemporal dementia 
Alzheimer disease, type 9 Pick's disease 
APP POLYMORPHISM 
Alzheimer disease, familial, with spastic  
paraparesis and unusual plaques 
Abnormality of lipid metabolism Cardiomyopathy, dilated, 1u 
Huntington disease-like syndrome 
Alzheimer disease, familial, 3, with spastic  
paraparesis and apraxia 
Hereditary cerebral hemorrhage with 
amyloidosis 
PRNP-associated condition 
Vascular dementia, susceptibility to Leigh syndrome 
Atransferrinemia Parkinson disease, late-onset 
Transferrin variant c1/c2 Alzheimer disease 19 
NA  
 
